Ketryx
AI-powered compliance platform for regulated software development.
Company facts
- Founded
- 2023
- Employees
- 100
- Headquarters
- United States
- CEO
- Erez Kaminski
- Type
- Private
- Funding
- Series B · $39M · 2025
About
Ketryx is dedicated to revolutionizing the way medical device software is developed by providing AI-powered FDA regulatory compliance software that significantly accelerates the development process. Our customers face the challenge of navigating complex and time-consuming validation processes, which is why we created Ketryx, the only developer-first connected lifecycle management platform specifically designed for the life sciences industry. By integrating with popular tools like Jira and GitHub, we ensure that teams can enforce Quality Management Systems (QMS) while maintaining compliance with regulatory standards. Our innovative solutions facilitate the management of traceability, documentation, and risk management, allowing MedTech companies to compress their product development timelines to mere weeks instead of months. Ketryx's automated features enhance collaboration across development, quality assurance, and regulatory teams, minimizing manual processes and ensuring accountability. By using our platform, clients streamline their workflows, achieve a single source of truth for their development efforts, and ultimately enhance the speed at which they can deliver life-saving technologies to market.